CompletedPhase 3NCT00351273

Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria

Studying Reactive arthritis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of South Florida
Principal Investigator: John D. Carter, MD
University of South Florida
Intervention: Doxycycline and Rifampin(drug)
Enrollment: 42 target
Eligibility: 18-70 years · All sexes
Timeline: 2006 – 2008

Study locations (3)

University of South Florida, Tampa, Florida, United States
Louisiana State University, New Orleans, Louisiana, United States
University of Toronto, Toronto, Ontario, Canada

Collaborators

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00351273 on ClinicalTrials.gov

Other trials for Reactive arthritis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center

See all trials for Reactive arthritis →

← Back to all trials